Cargando…
PARP inhibitors are not all equal
To many investigators PARP1 is simply a substrate for caspase 3, and whose cleavage is thought indicative of apoptosis. However, in reality PARP1 plays a major role in the biology of the cell cycle and DNA repair.(1)(,)(2) PARP1 binds to damaged DNA where it becomes enzymatically activated and ADP r...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926879/ https://www.ncbi.nlm.nih.gov/pubmed/24025256 http://dx.doi.org/10.4161/cbt.26160 |
_version_ | 1782304033832173568 |
---|---|
author | Dent, Paul |
author_facet | Dent, Paul |
author_sort | Dent, Paul |
collection | PubMed |
description | To many investigators PARP1 is simply a substrate for caspase 3, and whose cleavage is thought indicative of apoptosis. However, in reality PARP1 plays a major role in the biology of the cell cycle and DNA repair.(1)(,)(2) PARP1 binds to damaged DNA where it becomes enzymatically activated and ADP ribosylates itself and other proteins. PARP facilitates DNA repair complex formation, e.g., with BRCA1/2, and the activation of the cell cycle regulatory enzymes ATM and ATR.(2) PARP inhibitors as a single agent have only shown any degree of efficacy in breast and ovarian cancer patients who lack BRCA1/2 function.(3)(,)(4) The present studies examined PARP1 inhibitor biology in a range of triple negative and non-triple negative breast cancer cell lines. |
format | Online Article Text |
id | pubmed-3926879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Landes Bioscience |
record_format | MEDLINE/PubMed |
spelling | pubmed-39268792014-02-26 PARP inhibitors are not all equal Dent, Paul Cancer Biol Ther Commentary To many investigators PARP1 is simply a substrate for caspase 3, and whose cleavage is thought indicative of apoptosis. However, in reality PARP1 plays a major role in the biology of the cell cycle and DNA repair.(1)(,)(2) PARP1 binds to damaged DNA where it becomes enzymatically activated and ADP ribosylates itself and other proteins. PARP facilitates DNA repair complex formation, e.g., with BRCA1/2, and the activation of the cell cycle regulatory enzymes ATM and ATR.(2) PARP inhibitors as a single agent have only shown any degree of efficacy in breast and ovarian cancer patients who lack BRCA1/2 function.(3)(,)(4) The present studies examined PARP1 inhibitor biology in a range of triple negative and non-triple negative breast cancer cell lines. Landes Bioscience 2013-10-01 2013-08-26 /pmc/articles/PMC3926879/ /pubmed/24025256 http://dx.doi.org/10.4161/cbt.26160 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Commentary Dent, Paul PARP inhibitors are not all equal |
title | PARP inhibitors are not all equal |
title_full | PARP inhibitors are not all equal |
title_fullStr | PARP inhibitors are not all equal |
title_full_unstemmed | PARP inhibitors are not all equal |
title_short | PARP inhibitors are not all equal |
title_sort | parp inhibitors are not all equal |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926879/ https://www.ncbi.nlm.nih.gov/pubmed/24025256 http://dx.doi.org/10.4161/cbt.26160 |
work_keys_str_mv | AT dentpaul parpinhibitorsarenotallequal |